Therapeutic perspectives of epigenetically active nutrients

British Journal of Pharmacology

Volumn 172, Issue 11, 2015, Pages 2756-2768

  Remely, M ^a   Lovrecic, L ^b   De La Garza, A L ^c   Migliore, L ^d   Peterlin, B ^b   Milagro, F I ^c   Martinez, A J ^c,e   Haslberger, A G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF NAVARRA   (Spain)

^d UNIVERSITY OF PISA   (Italy)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DAIDZEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GEMCITABINE; GENISTEIN; MINERAL; POLYPHENOL; SELENIUM; ANTINEOPLASTIC AGENT; COFFEE; CYANOCOBALAMIN; FOLIC ACID; PHYTOESTROGEN; S ADENOSYLMETHIONINE; TRACE ELEMENT; VITAMIN; VITAMIN B COMPLEX;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ATHEROSCLEROSIS; BREAST CANCER; CANCER PREVENTION; CLINICAL EFFECTIVENESS; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG RESPONSE; ENDOCRINE DISEASE; ENZYME ACTIVITY; ENZYME ASSAY; EPIGENETICS; GENE EXPRESSION; HUMAN; HYPERTENSION; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; MOLECULAR DYNAMICS; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; PANCREAS CANCER; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; COFFEE; DIET; DRUG EFFECTS; FOOD; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; NEOPLASM;

ANTINEOPLASTIC AGENTS; COFFEE; CURCUMIN; DIET; EPIGENESIS, GENETIC; FOLIC ACID; FOOD; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METABOLIC SYNDROME X; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHYTOESTROGENS; POLYPHENOLS; S-ADENOSYLMETHIONINE; SELENIUM; TRACE ELEMENTS; VITAMIN B 12; VITAMIN B COMPLEX; VITAMINS;

EID: 84929208390     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12854     Document Type: Review

References (139)

1. Adwan L, Zawia NH, (2013). Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease. Pharmacol Ther 1: 41-50.
2. Alberti KG, Zimmet P, Shaw J, (2005). The metabolic syndrome-a new worldwide definition. Lancet 9491: 1059-1062.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. British Journal of Pharmacology, 170: 1797-1867.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors. Br J Pharmacol 170, 1652-1675
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding, M, et al (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors. British Journal of Pharmacology, 170, 1676-1705
6. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, et al. (2010). Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 9: 3606-3617.
7. Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC, (1999). Health potential of soy isoflavones for menopausal women. Public Health Nutr 4: 489-504.
8. Anderson JW, Smith BM, Washnock CS, (1999). Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 3 (Suppl.): 464S-474S.
9. Ayissi VB, Ebrahimi A, Schluesenner H, (2014). Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res 1: 22-32.
10. Azadbakht L, Nurbakhsh S, (2011). Effect of soy drink replacement in a weight reducing diet on anthropometric values and blood pressure among overweight and obese female youths. Asia Pac J Clin Nutr 3: 383-389.
11. Baer DJ, Stote KS, Paul DR, Harris GK, Rumpler WV, Clevidence BA, (2011). Whey protein but not soy protein supplementation alters body weight and composition in free-living overweight and obese adults. J Nutr 8: 1489-1494.
12. Boque N, de la Iglesia R, de la Garza AL, Milagro FI, Olivares M, Banuelos O, et al. (2013). Prevention of diet-induced obesity by apple polyphenols in Wistar rats through regulation of adipocyte gene expression and DNA methylation patterns. Mol Nutr Food Res 8: 1473-1478.
13. Branca F, (2003). Dietary phyto-oestrogens and bone health. Proc Nutr Soc 4: 877-887.
14. Brandl A, Heinzel T, Kramer OH, (2009). Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell 4: 193-205.
15. Brosch G, Loidl P, Graessle S, (2008). Histone modifications and chromatin dynamics: a focus on filamentous fungi. FEMS Microbiol Rev 3: 409-439.
16. Cheung KL, Kong AN, (2010). Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 1: 87-97.
17. Chittka A, Chittka L, (2010). Epigenetics of royalty. PLoS Biol 11: e1000532.
18. Cho CE, Sanchez-Hernandez D, Reza-Lopez SA, Huot PS, Kim YI, Anderson GH, (2013). High folate gestational and post-weaning diets alter hypothalamic feeding pathways by DNA methylation in Wistar rat offspring. Epigenetics 7: 710-719.
19. Choi DY, Lee YJ, Hong JT, Lee HJ, (2012). Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Brain Res Bull 2-3: 144-153.
20. Choi SW, Friso S, (2010). Epigenetics: a new bridge between nutrition and health. Adv Nutr 1: 8-16.
21. Choquette S, Riesco E, Cormier E, Dion T, Aubertin-Leheudre M, Dionne IJ, (2011). Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial. Br J Nutr 8: 1199-1209.
22. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S, (2012). Curcumin extract for prevention of type 2 diabetes. Diabetes Care 11: 2121-2127.
23. Coppede F, (2012). Genetics and epigenetics of Parkinson's disease. ScientificWorldJournal 2012: 489830.
24. Cordero P, Campion J, Milagro FI, Goyenechea E, Steemburgo T, Javierre BM, et al. (2011). Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem 3: 463-470.
25. Cordero P, Campion J, Milagro FI, Martinez JA, (2013a). Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation. Mol Genet Metab 3: 388-395.
26. Cordero P, Gomez-Uriz AM, Campion J, Milagro FI, Martinez JA, (2013b). Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet. Genes Nutr 8: 105-113.
27. Cotter A, Cashman KD, (2003). Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 10: 346-351.
28. Cyr AR, Hitchler MJ, Domann FE, (2013). Regulation of SOD2 in cancer by histone modifications and CpG methylation: closing the loop between redox biology and epigenetics. Antioxid Redox Signal 15: 1946-1955.
29. Dashwood RH, Ho E, (2007). Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 5: 363-369.
30. Davis CD, Uthus EO, Finley JW, (2000). Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 12: 2903-2909.
31. Day JJ, Sweatt JD, (2012). Epigenetic treatments for cognitive impairments. Neuropsychopharmacology 1: 247-260.
32. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491-4499.
33. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL, (2006). Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 4: 567-572.
34. Ebrahimi A, Schluesener H, (2012). Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res Rev 2: 329-345.
35. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ, (2010). The metabolic syndrome. Lancet 9710: 181-183.
36. Eliseeva ED, Valkov V, Jung M, Jung MO, (2007). Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 9: 2391-2398.
37. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ, (2012). Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res 9: 1829-1842.
38. Fan J, Yin WJ, Lu JS, Wang L, Wu J, Wu FY, et al. (2008). ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. J Cancer Res Clin Oncol 8: 883-890.
39. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS, (2005). Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 19 (Pt 1): 7033-7041.
40. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. (2004). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 6: 1374-1403.
41. Forges T, Monnier-Barbarino P, Alberto JM, Gueant-Rodriguez RM, Daval JL, Gueant JL, (2007). Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update 3: 225-238.
42. Fraga CG, Galleano M, Verstraeten SV, Oteiza PI, (2010). Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med 6: 435-445.
43. Franke AA, Lai JF, Halm BM, Pagano I, Kono N, Mack WJ, et al. (2011). Equol production changes over time in postmenopausal women. J Nutr Biochem 23: 573-579.
44. Franke AA, Lai JF, Pagano I, Morimoto Y, Maskarinec G, (2012). Equol production changes over time in pre-menopausal women. Br J Nutr 8: 1201-1206.
45. Frankenfeld CL, Atkinson C, Thomas WK, Gonzalez A, Jokela T, Wahala K, et al. (2005). High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart. Br J Nutr 6: 873-876.
46. Franks PW, Ling C, (2010). Epigenetics and obesity: the devil is in the details. BMC Med 8: 88.
47. Frick KM, Zhao Z, Fan L, (2011). The epigenetics of estrogen: epigenetic regulation of hormone-induced memory enhancement. Epigenetics 6: 675-680.
48. Fujimoto K, Tanaka M, Hirao Y, Nagata Y, Mori M, Miyanaga N, et al. (2008). Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men. Prostate Cancer Prostatic Dis 3: 252-257.
49. Fuks F, (2005). DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 5: 490-495.
50. Gardana C, Canzi E, Simonetti P, (2009). The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers. J Nutr Biochem 12: 940-947.
51. Gargari BP, Aghamohammadi V, Aliasgharzadeh A, (2011). Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract 1: 33-38.
52. Gilbert ER, Liu D, (2013). Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic beta-cell function. Food Funct 2: 200-212.
53. Gray SG, (2011). Epigenetic treatment of neurological disease. Epigenomics 4: 431-450.
54. Haberland M, Montgomery RL, Olson EN, (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 1: 32-42.
55. Harrison IF, Dexter DT, (2013). Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Pharmacol Ther 1: 34-52.
56. Helferich WG, Andrade JE, Hoagland MS, (2008). Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 5: 219-226.
57. Hilakivi-Clarke L, Andrade JE, Helferich W, (2010). Is soy consumption good or bad for the breast? J Nutr 12: 2326S-2334S.
58. Hong KW, Ko KP, Ahn Y, Kim CS, Park SJ, Park JK, et al. (2012). Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype. Genes Nutr 7: 567-574.
59. Howard TD, Ho SM, Zhang L, Chen J, Cui W, Slager R, et al. (2011). Epigenetic changes with dietary soy in cynomolgus monkeys. PLoS ONE 10: e26791.
60. Ichimura A, Hirasawa A, Hara T, Tsujimoto G, (2009). Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Prostaglandins Other Lipid Mediat 3-4: 82-88.
61. Jakovcevski M, Akbarian S, (2013). Epigenetic mechanisms in neurological disease. Nat Med 8: 1194-1204.
62. Jenks BH, Iwashita S, Nakagawa Y, Ragland K, Lee J, Carson WH, et al. (2012). A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency and other menopausal symptoms. J Womens Health (Larchmt) 21: 674-682.
63. Jiang Y, Gong P, Madak-Erdogan Z, Martin T, Jeyakumar M, Carlson K, et al. (2013). Mechanisms enforcing the estrogen receptor beta selectivity of botanical estrogens. FASEB J 11: 4406-4418.
64. Jimenez-Chillaron JC, Diaz R, Martinez D, Pentinat T, Ramon-Krauel M, Ribo S, et al. (2012). The role of nutrition on epigenetic modifications and their implications on health. Biochimie 11: 2242-2263.
65. Kalani A, Kamat PK, Givvimani S, Brown K, Metreveli N, Tyagi SC, et al. (2014). Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid. J Mol Neurosci 2: 202-215.
66. Kang KS, Yamabe N, Wen Y, Fukui M, Zhu BT, (2013). Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration. Brain Res 1497: 1-14.
67. Kelsey NA, Wilkins HM, Linseman DA, (2010). Nutraceutical antioxidants as novel neuroprotective agents. Molecules 11: 7792-7814.
68. Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, et al. (2012). Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila) 2: 309-319.
69. Kim HJ, Kim SH, Yun JM, (2012). Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms. Evid Based Complement Alternat Med 2012: 639469.
70. Kim M, Marsh EN, Kim SU, Han J, (2010). Conversion of (3S,4R)-tetrahydrodaidzein to (3S)-equol by THD reductase: proposed mechanism involving a radical intermediate. Biochemistry 26: 5582-5587.
71. Klose RJ, Bird AP, (2006). Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2: 89-97.
72. Ko TF, Tsai HS, Lin SM, Liu CD, Learn SP, Chiou RY, (2010). GC-MS determined distribution of urinary equol producers as affected by age, gender, and repeated ingestions of soymilk. J Food Sci 9: H306-H310.
73. Kondo T, (2006). Epigenetic alchemy for cell fate conversion. Curr Opin Genet Dev 5: 502-507.
74. Lampe JW, Karr SC, Hutchins AM, Slavin JL, (1998). Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 3: 335-339.
75. Lee WJ, Zhu BT, (2006). Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2: 269-277.
76. Li Y, Liu L, Andrews LG, Tollefsbol TO, (2009). Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer 2: 286-296.
77. Li Y, VandenBoom TG 2nd, Kong D, Wang Z, Ali S, Philip PA, et al. (2009). Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 16: 6704-6712.
78. Link A, Balaguer F, Goel A, (2010). Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 12: 1771-1792.
79. Liu HL, Chen Y, Cui GH, Zhou JF, (2005). Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol Sin 5: 603-609.
80. Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, et al. (2009). Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 3: 706-709.
81. Liu ZM, Ho SC, Chen YM, Woo J, (2013). A six-month randomized controlled trial of whole soy and isoflavones daidzein on body composition in equol-producing postmenopausal women with prehypertension. J Obes 2013: 359763.
82. Louis P, Flint HJ, (2007). Development of a semiquantitative degenerate real-time PCR-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol 6: 2009-2012.
83. Lu LJ, Anderson KE, Grady JJ, Nagamani M, (1996). Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 1: 63-70.
84. Maloney CA, Hay SM, Rees WD, (2009). The effects of feeding rats diets deficient in folic acid and related methyl donors on the blood pressure and glucose tolerance of the offspring. Br J Nutr 9: 1333-1340.
85. Maloney CA, Hay SM, Young LE, Sinclair KD, Rees WD, (2011). A methyl-deficient diet fed to rat dams during the peri-conception period programs glucose homeostasis in adult male but not female offspring. J Nutr 1: 95-100.
86. Mann M, Cortez V, Vadlamudi RK, (2011). Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy. Cancers (Basel) 3: 1691-1707.
87. Manson MM, (2003). Cancer prevention-the potential for diet to modulate molecular signalling. Trends Mol Med 1: 11-18.
88. Marcu MG, Jung YJ, Lee S, Chung EJ, Lee MJ, Trepel J, et al. (2006). Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2: 169-174.
89. Markesbery WR, (1997). Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1: 134-147.
90. Mehler MF, Mattick JS, (2007). Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev 3: 799-823.
91. Migliore L, Coppede F, (2009). Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res 1-2: 82-97.
92. Milagro FI, Mansego ML, De Miguel C, Martinez JA, (2013). Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. Mol Aspects Med 4: 782-812.
93. Milenkovic D, Deval C, Gouranton E, Landrier JF, Scalbert A, Morand C, et al. (2012). Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS ONE 1: e29837.
94. Nachtigal MC, Patterson RE, Stratton KL, Adams LA, Shattuck AL, White E, (2005). Dietary supplements and weight control in a middle-age population. J Altern Complement Med 5: 909-915.
95. Nielsen FH, (2010). Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 6: 333-340.
96. Oliver SS, Denu JM, (2011). Dynamic interplay between histone H3 modifications and protein interpreters: emerging evidence for a 'histone language'. Chembiochem 2: 299-307.
97. Pham TX, Lee J, (2012). Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases. Nutrients 12: 1868-1886.
98. Pinto JT, Lee JI, Sinha R, MacEwan ME, Cooper AJ, (2011). Chemopreventive mechanisms of alpha-keto acid metabolites of naturally occurring organoselenium compounds. Amino Acids 1: 29-41.
99. Plagemann A, Roepke K, Harder T, Brunn M, Harder A, Wittrock-Staar M, et al. (2010). Epigenetic malprogramming of the insulin receptor promoter due to developmental overfeeding. J Perinat Med 4: 393-400.
100. Pogribny IP, Tryndyak VP, Bagnyukova TV, Melnyk S, Montgomery B, Ross SA, et al. (2009). Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 1: 176-186.
101. Pooya S, Blaise S, Moreno Garcia M, Giudicelli J, Alberto JM, Gueant-Rodriguez RM, et al. (2012). Methyl donor deficiency impairs fatty acid oxidation through PGC-1alpha hypomethylation and decreased ER-alpha, ERR-alpha, and HNF-4alpha in the rat liver. J Hepatol 2: 344-351.
102. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-1106
103. Qin W, Zhu W, Shi H, Hewett JE, Ruhlen RL, MacDonald RS, et al. (2009). Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr Cancer 2: 238-244.
104. Remely M, Aumueller E, Merold C, Dworzak S, Hippe B, Zanner J, et al. (2013). Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 1: 85-92.
105. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB, (2011). Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 2: 93-108.
106. Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L, Calder AG, et al. (2013). Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol Nutr Food Res 3: 523-535.
107. Sawicka A, Seiser C, (2012). Histone H3 phosphorylation-a versatile chromatin modification for different occasions. Biochimie 11: 2193-2201.
108. Saxena NK, Sharma D, (2010). Epigenetic reactivation of estrogen receptor: promising tools for restoring response to endocrine therapy. Mol Cell Pharmacol 5: 191-202.
109. Scarpa S, Cavallaro RA, D'Anselmi F, Fuso A, (2006). Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J Alzheimers Dis 4: 407-414.
110. Schloegl H, Percik R, Horstmann A, Villringer A, Stumvoll M, (2010). Peptide hormones regulating appetite-focus on neuroimaging studies in humans. Diabetes Metab Res Rev 2: 104-112.
111. Scott RR, Miller WL, (2008). Genetic and clinical features of p450 oxidoreductase deficiency. Horm Res 5: 266-275.
112. Setchell KD, Brown NM, Lydeking-Olsen E, (2002). The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 12: 3577-3584.
113. Simoes-Pires C, Zwick V, Nurisso A, Schenker E, Carrupt PA, Cuendet M, (2013). HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener 8: 7.
114. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, et al. (2007). DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A 49: 19351-19356.
115. Squadrito F, Marini H, Bitto A, Altavilla D, Polito F, Adamo EB, et al. (2013). Genistein in the metabolic syndrome: results of a randomized clinical trial. J Clin Endocrinol Metab 8: 3366-3374.
116. Stangl D, Thuret S, (2009). Impact of diet on adult hippocampal neurogenesis. Genes Nutr 4: 271-282.
117. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, et al. (2011). Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 17: 5891-5903.
118. Stewart CP, Christian P, LeClerq SC, West KP Jr, Khatry SK, (2009). Antenatal supplementation with folic acid + iron + zinc improves linear growth and reduces peripheral adiposity in school-age children in rural Nepal. Am J Clin Nutr 1: 132-140.
119. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R, (2008). Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 3: 464-473.
120. Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M, et al. (2008). Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 10: 4880-4891.
121. Takahira M, Noda K, Fukushima M, Zhang B, Mitsutake R, Uehara Y, et al. (2011). Randomized, double-blind, controlled, comparative trial of formula food containing soy protein vs. milk protein in visceral fat obesity-FLAVO study. Circ J 9: 2235-2243.
122. Takaya J, Iharada A, Okihana H, Kaneko K, (2011). Magnesium deficiency in pregnant rats alters methylation of specific cytosines in the hepatic hydroxysteroid dehydrogenase-2 promoter of the offspring. Epigenetics 5: 573-578.
123. Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M, (2012). Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause 19: 776-790.
124. Tammen SA, Friso S, Choi SW, (2013). Epigenetics: the link between nature and nurture. Mol Aspects Med 4: 753-764.
125. Traka M, Gasper AV, Smith JA, Hawkey CJ, Bao Y, Mithen RF, (2005). Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J Nutr 8: 1865-1872.
126. Tsankova N, Renthal W, Kumar A, Nestler EJ, (2007). Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 5: 355-367.
127. Urdinguio RG, Sanchez-Mut JV, Esteller M, (2009). Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 11: 1056-1072.
128. Usui T, Tochiya M, Sasaki Y, Muranaka K, Yamakage H, Himeno A, et al. (2012). Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin Endocrinol (Oxf) 78: 365-372.
129. Valgimigli L, Iori R, (2009). Antioxidant and pro-oxidant capacities of ITCs. Environ Mol Mutagen 3: 222-237.
130. Varela MA, Roberts TC, Wood MJ, (2013). Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy. Neurother 4: 621-631.
131. Vaughn N, Rizzo A, Doane D, Beverly JL, Gonzalez de Mejia E, (2008). Intracerebroventricular administration of soy protein hydrolysates reduces body weight without affecting food intake in rats. Plant Foods Hum Nutr 1: 41-46.
132. Vincent A, Fitzpatrick LA, (2000). Soy isoflavones: are they useful in menopause? Mayo Clin Proc 11: 1174-1184.
133. Wang Z, Yao T, Pini M, Zhou Z, Fantuzzi G, Song Z, (2010). Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 5: G634-G642.
134. Winkler JM, Fox HS, (2013). Transcriptome meta-analysis reveals a central role for sex steroids in the degeneration of hippocampal neurons in Alzheimer's disease. BMC Syst Biol 7: 51.
135. Yajnik CS, Deshmukh US, (2008). Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord 3: 203-211.
136. Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, et al. (2002). Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 12: 5575-5580.
137. Yamori Y, (2004). Worldwide epidemic of obesity: hope for Japanese diets. Clin Exp Pharmacol Physiol 31 (Suppl.): S2-S4.
138. Ye YB, Wang ZL, Zhuo SY, Lu W, Liao HF, Verbruggen MA, et al. (2012). Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial. Menopause 19: 791-798.
139. Zhao B, (2009). Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease. Neurochem Res 4: 630-638.